Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in Situ hybridization

Cancer Research

Volumn 57, Issue 3, 1997, Pages 524-531

  Jenkins, Robert B ^a   Qian, Junqi ^a   Lieber, Michael M ^a   Bostwick, David G ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN;

ADULT; AGED; ARTICLE; CARCINOMA IN SITU; CENTROMERE; CHROMOSOME 8; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION; GENETIC HETEROGENEITY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; ONCOGENE C MYC; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY;

AGED; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 8; GENE AMPLIFICATION; GENES, MYC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MYC; REFERENCE VALUES;

EID: 0031059179     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics. CA Cancer J. Clin., 46: 5-28, 1996.
2. Johansson, J. E., Adami, M. D., Andersson, S. O., Bergstrom, R., Krusemo, U. B., and Kraaz, W. Natural history of localized prostate cancer: a population based study in 223 untreated patients. Lancet, 1: 799, 1989.
3. Bostwick, D. G., and Brawer, M. K. Prostatic intra-epithelial neoplasia and early invasion in prostate cancer. Cancer (Phila.), 59: 788-794, 1987.
4. McNeal, J. E., and Bostwick, D. G. Intraductal dysplasia: a premalignant lesion of the prostate. Hum. Pathol., 17: 64-71, 1986.
5. McNeal, J. E., Alroy, J., Leav, I., Redwine, E. A., Freina, F. S., and Stamey, T. A. Immunohistochemical evidence for impaired cell differentiation in the premalignant phase of prostate carcinogenesis. Am. J. Clin. Pathol., 90: 23-32, 1988.
6. Davidson, D., Bostwick, D. G., Qian, J., Wollan, P., Osterling, J. E., Rudders, R. A., Siroky, M., and Slilmant, M. Prostatic intraepithelial neoplasia is predictive of adenocarcinoma. J. Urol., 154: 1295-1299, 1995.
7. Bostwick, D. G., Amin, M. B., Dundore, P., Marsh, W., and Schultz, D. S. Architectural patterns of high-grade prostatic intraepithelial neoplasia. Hum. Pathol., 24: 298-310, 1993.
8. Bostwick, D. G. High grade prostatic intraepithelial neoplasia: the most likely precursor of prostate cancer. Cancer (Phila.), 75: 1823-1836, 1995.
9. Alers, C. A., Krijtenburg, P. J., Vissers, K. J., Bosman, F. T., van der Kwast, T. H., and Dekken, H. Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions: analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias. Genes Chromosomes Cancer, 12: 241-250, 1995.
10. Qiun, J., Bostwick, D. G., Takahashi, S., Borell. T. J., Herath, J. F, Lieber, M. M., and Jenkins, R. B. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res., 55: 5408-5414, 1995.
11. Macoska, J. A., Trybus, T. M., Sakr, W. A., Wolf, M. C., Benson, P. D., Powell, I. J., and Pontes J. E. Fluorescence I'M situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Cancer Res., 54: 3824-3830, 1994.
12. Emmert-Buck, M. R., Vocke, C. D., Pozzatti, R. O., Duray, P. H., Jennings, S. B., Florence, C. D., Zhuang, Z., Bostwick, D. G., Liotta, L. A., and Linehan, W. L. Allelic loss on chromosome 8p 12-21 in microdissected prostatic intraepithelial neoplasia (PIN). Cancer Res., 55: 2959-2962, 1995.
13. Cher, M. L., MacGrogan, D., Bookstein, R., Brown, J. A., Jenkini, R. B., and Jensen, R. H. Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chromosomes Cancer, 11: 153-162, 1994.
14. Visakorpi, T., Kallioniemi, A. H., Syvanen, A. C., Hyytinen, E. R., Karhu, R., Tammela, T., Isola, J. J., and Kallioniemi, O. P. Genetic changes in primary and recurrent, prostate cancer by comparative genomic hybridization. Cancer Res., 55: 342-347, 1995.
15. Van Den Berg, C., Guan, X. Y., Von Hoff, D., Jenkins, R. B., Bitter, M., Griffin, C., Kallioniemi, O., Visakorpi, T., McGill, J., Herath, J. F., Epstein, J. I., Scarosdy, M., Meltzer, P., and Trent, J. DNA sequence amplification in human prostate cancer identified by chromosome microdissection: potential prognostic implications. Clin. Cancer Res., 7: 11-18, 1995.
16. Depinho, R., Schreiber-Agus, N., and Alt, F. W. Myc family oncogenes in the development of normal and neoplastic cells. Adv. Cancer Res., 57: 1-46, 1991.
17. Escot, C., Thellet, C., Lidereau, R., Spyratos, F., Champeme, M. H., Gest, M., and Callahan, R. Genetic alterations of the c-myc proto-oncogene in human primary breast carcinomas. Proc. Natl. Acad. Sci. USA, 83: 4834-4838, 1986.
18. Macoska, J. A., Micael, M. A., Sakr, W. A., Benson, P. D., and Wolman, S. R. Extensive genetic alterations in prostate cancer revealed by dual PCR and FISH analysis. Genes Chromosomes Cancer, 8: 88-97, 1993.
19. Takahashi, S., Qian, J., Brown, J. A., Alcaraz, A., Bostwick, D. G., Lieber, M. M., and Jenkins, R. B. Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization. Cancer Res., 54: 3574-3579, 1994.
20. Alcaraz, A., Takahashi, S., Brown, J. A., Herath, J. F., Bergstralh, E., Larson-Keller, J., Lieber, M. M., and Jenkins, R. B. Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. Cancer Res., 54: 3998-4002, 1994.
21. Persons, D. L., Gibney, D. J., Hatzmann, J. A., Lieber, M. M., Farrow, G. M., and Jenkins, R. B. Use of fluorescence in situ hybridization for deoxyribonucleic acid ploidy analysis of prostatic carcinoma. J. Urol., 150; 120-125, 1993.
22. Brown, J. A., Alcaraz, A., Takahashi, S., Persons, D. L., Lieber, M. M., and Jenkins, R. B. Chromosomal aneusomies detected by fluorescence in situ hybridization analysis in clinically localized prostate carcinoma. J. Urol., 152: 1157-1162, 1994.
23. Bostwick, D. G. Gleason grading of prostatic needle biopsies; correlation with grade in 316 matched prostatectomies. Am. J. Surg, Pathol., 18: 796-803, 1994.
24. Fleming, W. H., Hamel, A., McDonald, R., Ramsey, E., Pettigrew, N. M., Johnston, B., Dodd, J. G., and Matusik, R. J. Expression of the c-myc proto-oncogene in human prostatic carcinoma and benign prostatic hyperplasia. Cancer Res., 46: 1535-1537, 1986.
25. Brog, A., Baldetrop, B., Ferno, M., Olsson, H., and Sigurdsson, H. C-myc amplification is an independent prognostic factor in postmenopausal breast cancer. Int. J. Cancer, 51: 687-691, 1992.
26. Qian, J., Wollan, P., and Bostwick, D. G. The extent and multicentricity of high grade intraepithelial neoplasia in clinically localized prostatic adenocarcinoma. Hum. Pathol., in press, 1997.
27. Bostwick, D. G., and Qian, J. Atypical adenomatous hyperplasia of the prostate: relationship with carcinoma in 217 whole mount radical prostatectomies. Am. J. Surg. Pathol., 19: 506-518, 1995.
28. Greene, D. R., Rogers, E., Wessels, E. C., Wheeler, T. M., Taylor, S. R., Santucci, R. A., Thompson, T. C., and Scardino, P. T. Some small prostate cancers are nondiploid by nuclear image analysis: correlation of deoxyribonucleic acid ploidy status and pathological features. J. Urol., 151: 1301-1307, 1994.
29. Mirchandani, D., Zheng, J., Miller, G. J., Ghosh, A. K., Shibata, D. K., Cote, R. J., and Roy-Burman, P. Heterogeneity in intratumor distribution of p53 mutations in human prostate cancer. Am. J. Pathol., 147: 92-101, 1995.
30. Konishi, N., Hiasa, Y., Matsuda, H., Tao, M., Tsuzuki, T., Hayashi, I., Kitahori, Y., Shiraishi, T., Yatani, R., Shimazaki, J., and Lin, J. C. Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma. Am. J. Pathol., 147: 1112-1122, 1995.
31. Lu, X., Park, S. H., Thompson, T. C., and Lane, D. P. Ras-induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation. Cell, 70: 153-161, 1992.
32. Visakorpi, T., Hyytinen, E., Koivisto, P., Tanner, M., Keinanen, R., Palmberg, C., Palotie, A., Tammela, T., Isola, J., and Kallioniemi, O. P. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat. Genet., 9: 401-406, 1995.
33. Effert, P. J., Neubauer, A., Walther, P. J., and Liu, E. T. Alterations of p53 gene are associated with the progression of a human prostate carcinoma. J. Urol., 147: 789-793, 1992.
34. Macoska, J. A., Powell, I. J., Sakr, W. A., and Lane, M. Loss of the 17p chromosomal region in a metastatic carcinoma of the prostate. J. Urol., 147: 1142-1146, 1992.
35. Steilen, H., Ketter, R., Romanakis, K., Zwergel, T., Unteregger, G., Bonkhoff, H., Seitz, G., Ziegler, M., Zang, K. D., and Wullich, B. DNA aneuploidy in prostatic carcinoma: a frequent event as shown by fluorescence in situ DNA hybridization. Hum. Pathol., 25: 1306-1313, 1994.
36. Sakr, W. A., Macoska, J. A., Benson, P. D., Grignon, D. J., Wolman, S. R., Pontes, J. E., and Crissman, J. D. Allelic loss in locally metastatic, multi sampled prostate cancer. Cancer Res., 54: 3273-3279, 1994.